(AFRM) Affirm Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US00827B1061
Stock: Point-Of-Sale, Installment, Merchant, App, Consumer
Total Rating 18
Risk 37
Buy Signal -0.79
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 77.8% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -38.10 |
| Character TTM | |
|---|---|
| Beta | 2.380 |
| Beta Downside | 2.429 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.85% |
| CAGR/Max DD | 1.19 |
Description: AFRM Affirm Holdings December 17, 2025
Affirm Holdings, Inc. (NASDAQ: AFRM) operates a U.S.-based payment network that extends to Canada and other international markets, offering a point-of-sale financing solution, merchant commerce tools, and a consumer-facing app that lets shoppers split purchases into installments.
In FY 2023 the company reported roughly $1.5 billion in revenue and processed about $15 billion in total payment volume, reflecting a year-over-year growth rate near 20 % despite a net loss of $300 million as it invests in technology and expands its merchant base.
The buy-now-pay-later (BNPL) sector is being shaped by a 12 % CAGR in consumer demand, tighter credit conditions from rising interest rates, and intensifying competition from both fintechs and traditional card issuers-all of which directly affect Affirm’s pricing power and merchant adoption rates.
For a deeper quantitative dive into AFRM’s risk-adjusted valuation, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 282.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.07 > 1.0 |
| NWC/Revenue: 84.29% < 20% (prev 320.0%; Δ -235.7% < -1%) |
| CFO/TA 0.06 > 3% & CFO 833.3m > Net Income 282.3m |
| Net Debt (-400.2m) to EBITDA (789.9m): -0.51 < 3 |
| Current Ratio: 44.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (349.4m) vs 12m ago 1.21% < -2% |
| Gross Margin: 58.94% > 18% (prev 0.67%; Δ 5827 % > 0.5%) |
| Asset Turnover: 24.93% > 50% (prev 26.72%; Δ -1.79% > 0%) |
| Interest Coverage Ratio: 1.11 > 6 (EBITDA TTM 789.9m / Interest Expense TTM 435.3m) |
Altman Z'' 0.49
| A: 0.19 (Total Current Assets 2.52b - Total Current Liabilities 57.2m) / Total Assets 12.96b |
| B: -0.22 (Retained Earnings -2.85b / Total Assets 12.96b) |
| C: 0.04 (EBIT TTM 483.5m / Avg Total Assets 11.72b) |
| D: -0.30 (Book Value of Equity -2.86b / Total Liabilities 9.41b) |
| Altman-Z'' Score: 0.49 = B |
Beneish M 1.00
| DSRI: 0.04 (Receivables 268.2m/6.65b, Revenue 2.92b/2.80b) |
| GMI: 1.14 (GM 58.94% / 67.14%) |
| AQI: 9.35 (AQ_t 0.76 / AQ_t-1 0.08) |
| SGI: 1.04 (Revenue 2.92b / 2.80b) |
| TATA: -0.04 (NI 282.3m - CFO 833.3m) / TA 12.96b) |
| Beneish M-Score: 1.25 (Cap -4..+1) = D |
What is the price of AFRM shares?
As of February 10, 2026, the stock is trading at USD 57.95 with a total of 7,829,451 shares traded.
Over the past week, the price has changed by -6.52%, over one month by -29.16%, over three months by -23.84% and over the past year by -25.47%.
Over the past week, the price has changed by -6.52%, over one month by -29.16%, over three months by -23.84% and over the past year by -25.47%.
Is AFRM a buy, sell or hold?
Affirm Holdings has received a consensus analysts rating of 4.17.
Therefore, it is recommended to buy AFRM.
- StrongBuy: 11
- Buy: 6
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AFRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.7 | 51.4% |
| Analysts Target Price | 87.7 | 51.4% |
| ValueRay Target Price | 58.1 | 0.3% |
AFRM Fundamental Data Overview February 08, 2026
P/E Trailing = 70.4074
P/E Forward = 58.4795
P/S = 5.1124
P/B = 5.3561
P/EG = 0.4431
Revenue TTM = 2.92b USD
EBIT TTM = 483.5m USD
EBITDA TTM = 789.9m USD
Long Term Debt = 9.14b USD (from longTermDebt, last quarter)
Short Term Debt = 199.8m USD (from shortTermDebt, last fiscal year)
Debt = 1.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -400.2m USD (from netDebt column, last quarter)
Enterprise Value = 17.87b USD (19.00b + Debt 1.13b - CCE 2.25b)
Interest Coverage Ratio = 1.11 (Ebit TTM 483.5m / Interest Expense TTM 435.3m)
EV/FCF = 28.87x (Enterprise Value 17.87b / FCF TTM 619.1m)
FCF Yield = 3.46% (FCF TTM 619.1m / Enterprise Value 17.87b)
FCF Margin = 21.19% (FCF TTM 619.1m / Revenue TTM 2.92b)
Net Margin = 9.66% (Net Income TTM 282.3m / Revenue TTM 2.92b)
Gross Margin = 58.94% ((Revenue TTM 2.92b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = -4.59% (prev 67.65%)
Tobins Q-Ratio = 1.38 (Enterprise Value 17.87b / Total Assets 12.96b)
Interest Expense / Debt = 9.91% (Interest Expense 111.7m / Debt 1.13b)
Taxrate = 2.74% (3.65m / 133.2m)
NOPAT = 470.3m (EBIT 483.5m * (1 - 2.74%))
Current Ratio = 44.02 (Total Current Assets 2.52b / Total Current Liabilities 57.2m)
Debt / Equity = 0.32 (Debt 1.13b / totalStockholderEquity, last quarter 3.55b)
Debt / EBITDA = -0.51 (Net Debt -400.2m / EBITDA 789.9m)
Debt / FCF = -0.65 (Net Debt -400.2m / FCF TTM 619.1m)
Total Stockholder Equity = 3.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.41% (Net Income 282.3m / Total Assets 12.96b)
RoE = 8.83% (Net Income TTM 282.3m / Total Stockholder Equity 3.20b)
RoCE = 3.92% (EBIT 483.5m / Capital Employed (Equity 3.20b + L.T.Debt 9.14b))
RoIC = 4.18% (NOPAT 470.3m / Invested Capital 11.25b)
WACC = 14.40% (E(19.00b)/V(20.12b) * Re(14.68%) + D(1.13b)/V(20.12b) * Rd(9.91%) * (1-Tc(0.03)))
Discount Rate = 14.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.51%
[DCF Debug] Terminal Value 51.08% ; FCFF base≈616.7m ; Y1≈462.1m ; Y5≈274.7m
Fair Price DCF = 9.77 (EV 2.46b - Net Debt -400.2m = Equity 2.86b / Shares 292.4m; r=14.40% [WACC]; 5y FCF grow -29.68% → 2.90% )
EPS Correlation: 82.40 | EPS CAGR: 19.43% | SUE: 2.69 | # QB: 1
Revenue Correlation: 67.69 | Revenue CAGR: -2.04% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.69 | Chg30d=-0.036 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-06-30): EPS=3.10 | Chg30d=+0.015 | Revisions Net=-2 | Growth EPS=+77.3% | Growth Revenue=+28.1%
EPS next Year (2027-06-30): EPS=3.81 | Chg30d=+0.008 | Revisions Net=-2 | Growth EPS=+23.1% | Growth Revenue=+23.7%
P/E Forward = 58.4795
P/S = 5.1124
P/B = 5.3561
P/EG = 0.4431
Revenue TTM = 2.92b USD
EBIT TTM = 483.5m USD
EBITDA TTM = 789.9m USD
Long Term Debt = 9.14b USD (from longTermDebt, last quarter)
Short Term Debt = 199.8m USD (from shortTermDebt, last fiscal year)
Debt = 1.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -400.2m USD (from netDebt column, last quarter)
Enterprise Value = 17.87b USD (19.00b + Debt 1.13b - CCE 2.25b)
Interest Coverage Ratio = 1.11 (Ebit TTM 483.5m / Interest Expense TTM 435.3m)
EV/FCF = 28.87x (Enterprise Value 17.87b / FCF TTM 619.1m)
FCF Yield = 3.46% (FCF TTM 619.1m / Enterprise Value 17.87b)
FCF Margin = 21.19% (FCF TTM 619.1m / Revenue TTM 2.92b)
Net Margin = 9.66% (Net Income TTM 282.3m / Revenue TTM 2.92b)
Gross Margin = 58.94% ((Revenue TTM 2.92b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = -4.59% (prev 67.65%)
Tobins Q-Ratio = 1.38 (Enterprise Value 17.87b / Total Assets 12.96b)
Interest Expense / Debt = 9.91% (Interest Expense 111.7m / Debt 1.13b)
Taxrate = 2.74% (3.65m / 133.2m)
NOPAT = 470.3m (EBIT 483.5m * (1 - 2.74%))
Current Ratio = 44.02 (Total Current Assets 2.52b / Total Current Liabilities 57.2m)
Debt / Equity = 0.32 (Debt 1.13b / totalStockholderEquity, last quarter 3.55b)
Debt / EBITDA = -0.51 (Net Debt -400.2m / EBITDA 789.9m)
Debt / FCF = -0.65 (Net Debt -400.2m / FCF TTM 619.1m)
Total Stockholder Equity = 3.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.41% (Net Income 282.3m / Total Assets 12.96b)
RoE = 8.83% (Net Income TTM 282.3m / Total Stockholder Equity 3.20b)
RoCE = 3.92% (EBIT 483.5m / Capital Employed (Equity 3.20b + L.T.Debt 9.14b))
RoIC = 4.18% (NOPAT 470.3m / Invested Capital 11.25b)
WACC = 14.40% (E(19.00b)/V(20.12b) * Re(14.68%) + D(1.13b)/V(20.12b) * Rd(9.91%) * (1-Tc(0.03)))
Discount Rate = 14.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.51%
[DCF Debug] Terminal Value 51.08% ; FCFF base≈616.7m ; Y1≈462.1m ; Y5≈274.7m
Fair Price DCF = 9.77 (EV 2.46b - Net Debt -400.2m = Equity 2.86b / Shares 292.4m; r=14.40% [WACC]; 5y FCF grow -29.68% → 2.90% )
EPS Correlation: 82.40 | EPS CAGR: 19.43% | SUE: 2.69 | # QB: 1
Revenue Correlation: 67.69 | Revenue CAGR: -2.04% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.69 | Chg30d=-0.036 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-06-30): EPS=3.10 | Chg30d=+0.015 | Revisions Net=-2 | Growth EPS=+77.3% | Growth Revenue=+28.1%
EPS next Year (2027-06-30): EPS=3.81 | Chg30d=+0.008 | Revisions Net=-2 | Growth EPS=+23.1% | Growth Revenue=+23.7%